References
- Andersson U, Butters TD, Dwek RA, Platt FM. Nbutyldeoxygalactonojirimycin: A more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and invivo. Biochem Pharmacol, 2000;59:821–9.
- Chavanpatil MD, Jain P, Chaudhari Shear R, Vavia PR. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int J Pharm, 2005;304:178–84.
- Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep, 2009;26:1001–43.
- Deshpande MC, Venkateswarlu V, Badu RK, Trivedi RK. Design and evaluation of oral bioadhesive controlled release formulations of mig;otol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels. Int J Pharm, 2009;380:16–24.
- Dévay A, Mayer K, Pάl S, Antal l. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear gramulation. J Biochem Biophys Methods, 2006;69:197–205.
- Do HJ, Chung JH, Hwang JW, Kim OY, Lee JY, Shin MJ. 1-Deoxynojirimycin isolated from Bacillus subtilis improves hepatic lipid metabolism and mitochondrial function in high-fat-fed mice. Food Chem. Toxicol, 2015;75:1–7.
- Fresta M, Guccione S, Beccari AR, Furneri PM, Puglisi G. Combining molecular modeling with experimental methodogies: mechanism of membrane permeation and accumulation of ofloxacin. Bioorg Med Chem, 2002;10:3871–89.
- Gu H, Rao D, Gandhi RB, Hilden J, Raghavan K. Using a novel multicompartment dissolution system to predict the effect of gastric ph on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci, 2005;94:199–208.
- Guan H, Huang H, Ou Y. Preparation, in vivo and in vitro study of dipyridamole-loaded sustained-release dripping pills. J China Pharm Univ, 2008;39:32–6.
- Hu LD, Liu Y, Tang X, Zhang Q. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur J Pharm Biopharm, 2006;64:185–92.
- Kalantzi L, Persson E, Polentarutti B, Abrahamsson B, Goumas K, Dressman JB, Reppas C. Canine intestinal contents vs. Simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res, 2006;23:1373–81.
- Kim JY, Kwon HJ, Jung JY, Kwon HY, Baek JG, Kim YS, Kwon O. Comparison of absorption of 1-deoxynojirimycin from mulberry water extract in rats. J Agric Food Chem, 2010;58:6666–71.
- Kojima Y, Kimura T, Nakagawa K, Asai A, Hasumi K, Miyazawa T. Effects of mulberry leaf extract rich in 1-deoxynojirimycin on blood lipid profiles in humans. J Clin Biochem Nutr, 2010;47:155–61.
- Kong WH, Oh SH, Ahn YR, Kim JH, Seo SW. Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models. J Agric Food Chem, 2008;56:2613–9.
- Li YG, Ji DF, Zhong S, Lin TB, Qiang Z. Hypoglycemic effect of deoxynojirimucin-polysaccharide on high fat diet and streptozotocin-induced diabetic mic via regulation of hepatic glucose metabolism. Chem Biol Interact, 2015;225:70–9.
- Mitrevej NSVJAA. Application of hot-melt coating for controlled release of propranolol hydrochloried pellets. Powder Technol, 2004;141:203–9.
- Nakagawa K, Kubota H, Kojima Y, Goto Y, Yamagishi K, Oita S, Oikawa S, Miyazawa T. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem, 2007;55:5869–74.
- Pukunaka Y, lwanaga K, Morimoto K, Kakemi M, Tabata Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release, 2002;80:333–43.
- Vichasilp C, Nakagawa K, Sookwong P, Higuchi O, Luemunkong S, Miyazawa T. Development of high 1-DNJ content mulberry tea and use of response surface methodogy to optimize tea-making conditions for highest DNJ extraction. LWT-Food Science and Technology, 2012;45:226–32.
- Wilding LAPDV. Remote controlled release capsules in human drug absorption (hda) studies. Crit Rev Ther Drug Carrier Syst, 2003;20:405–31.
- Yang ZY, Lu Y, Tang X. Pseudoephedrine hydrochloride sustained-release pellets prepared by a combination of hot-melt subcoating and polymer coating. Drug Dev lnd Pharm, 2008;34:1323–30.
- Zhang X, Chen X, Hu LD, Tang X, Li SM, Zhong D. Evaluation of in-vitro dissolution and in-vivo absorption for two different film-coated pellets of clarithromycin. Arch Pharm Res, 2005;28:977–82.
- Zhang ZH, Wang CG, Sun Sun GM, Li N, Peng B, Pan WS. Pharmacokinetics of two modified release system of dipyridamole in beagle dog. J Chin Pharm Sci, 2008;17:297–302.